Third, because of the COVID-19 pandemic, the number of samples collected in the 90-day anti-r-SAK antibody test was limited; however, sufficient samples were collected from 180 days to 360 days to evaluate antibody titers and safety of rethrombolysis. Here, PLK4 is linked to COVID-19.